CBD for Cannabis

"CBD has been demonstrated to be effective in treating those who suffer from inadequate response to conventional therapy, multiple sclerosis, and pharmacotherapy."

"Given the Phase 1 status of this trial, there is limited data on CBD's safety and efficacy; therefore, our team at Power gives it a score of 1."

"Patients aged 18 - 55 are eligible to enrol in this trial. There is a separate 36-trial study for minors and another 144-trial program open to older adults."

"Affirmative. According to clinicaltrials.gov, this research project is still recruiting patients since it was first posted on July 14th 2021 and recently updated on July 5th 2022. The trial aims to include 200 participants from a single site."

"This research is seeking 200 individuals with cannabis dependency aged between 18 and 55. Key criteria for participants include: having a SBP of 150 mmHg or lower and DBP of 90mmHg or less, presenting written informed consent, being within the specified age range, displaying general health based on physical examination, medical history, vitals signs and drug-screening tests (urine/blood), testing negative in recent urine screenings for marijuana use as well as other recreational substances including alcohol upon both screening visit and experimental session arrivals; if female – not pregnant nor nursing (with appropriate pregnancy test results at each study visit); BMI ranging 19"

"This clinical trial is aimed at gauging the Change in Blood cannabinoids over a 1, 2, 3, 7, 10 and 17 day period. Secondary objectives entail determining any shifts in Cognitive performance (measured as mean cursor distance from central stimulus with Divided Attention Task), Psychomotor performance (quantified by number of correct trials within 90 seconds on Digit Symbol Substitution Test) and Subjective drug effects (assessed via Drug Effect Questionnaire ranging 0-100)."

"Currently, 104 clinical research projects regarding Cannabidiol (CBD) are being conducted. 19 of these active studies have progressed to Phase 3. 331 sites across the United States are running trials for this potential therapy, with Belmont Massachusetts having a particularly high concentration of such studies."

"As per the clinicaltrials.gov listing, this trial is currently accepting enrollees. The study was initially posted on July 14th 2021 and has been revised most recently on July 5th 2022."